-
1
-
-
84921487109
-
Novel personalized therapies for cystic fibrosis: Treating the basic defect in all patients
-
Amaral MD. 2015. Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients. J Intern Med 277:155–166.
-
(2015)
J Intern Med
, vol.277
, pp. 155-166
-
-
Amaral, M.D.1
-
2
-
-
0141681935
-
EGCG corrects aberrant splicing of IKAP mRNA in cells frompatients with familial dysautonomia
-
Anderson SL, Qiu J, Rubin BY. 2003. EGCG corrects aberrant splicing of IKAP mRNA in cells frompatients with familial dysautonomia. Biochem Biophys Res Commun 310:627–633.
-
(2003)
Biochem Biophys Res Commun
, vol.310
, pp. 627-633
-
-
Anderson, S.L.1
Qiu, J.2
Rubin, B.Y.3
-
3
-
-
84918819788
-
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
-
Bell SC, De Boeck K, Amaral MD. 2015. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. Pharmacol Ther 145:19–34.
-
(2015)
Pharmacol Ther
, vol.145
, pp. 19-34
-
-
Bell, S.C.1
De Boeck, K.2
Amaral, M.D.3
-
4
-
-
84924871406
-
Protein traffic disorders: An effective high-throughput fluorescence microscopy pipeline for drug discovery
-
Botelho HM, Uliyakina I, Awatade NT, Proenca MC, Tischer C, Sirianant L, Kunzelmann K, Pepperkok R, Amaral MD. 2015. Protein traffic disorders: an effective high-throughput fluorescence microscopy pipeline for drug discovery. Sci Rep 5:9038.
-
(2015)
Sci Rep
, vol.5
, pp. 9038
-
-
Botelho, H.M.1
Uliyakina, I.2
Awatade, N.T.3
Proenca, M.C.4
Tischer, C.5
Sirianant, L.6
Kunzelmann, K.7
Pepperkok, R.8
Amaral, M.D.9
-
5
-
-
0035282581
-
Aberrant CFTR-dependent HCO3-transport in mutations associated with cystic fibrosis
-
Choi JY, Muallem D, Kiselyov K, Lee MG, Thomas PJ, Muallem S. 2001. Aberrant CFTR-dependent HCO3-transport in mutations associated with cystic fibrosis. Nature 410(6824):94–97.
-
(2001)
Nature
, vol.410
, Issue.6824
, pp. 94-97
-
-
Choi, J.Y.1
Muallem, D.2
Kiselyov, K.3
Lee, M.G.4
Thomas, P.J.5
Muallem, S.6
-
6
-
-
0026656343
-
Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis
-
Chu CS, Trapnell BC, Curristin SM, Cutting GR, Crystal RG. 1992. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J Clin Invest 90:785–790.
-
(1992)
J Clin Invest
, vol.90
, pp. 785-790
-
-
Chu, C.S.1
Trapnell, B.C.2
Curristin, S.M.3
Cutting, G.R.4
Crystal, R.G.5
-
7
-
-
77952733302
-
Genes,mutations, and human inherited disease at the dawn of the age of personalized genomics
-
Cooper DN, Chen JM, Ball EV, Howells K, Mort M, Phillips AD, Chuzhanova N, Krawczak M, Kehrer-Sawatzki H, Stenson PD. 2010. Genes,mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum Mutat 31:631–655.
-
(2010)
Hum Mutat
, vol.31
, pp. 631-655
-
-
Cooper, D.N.1
Chen, J.M.2
Ball, E.V.3
Howells, K.4
Mort, M.5
Phillips, A.D.6
Chuzhanova, N.7
Krawczak, M.8
Kehrer-Sawatzki, H.9
Stenson, P.D.10
-
8
-
-
84920733762
-
Improvement of SMN2pre-mRNA processing mediated by exon-specific U1 small nuclear RNA
-
DalMas A, Rogalska ME, Bussani E, Pagani F. 2015. Improvement of SMN2pre-mRNA processing mediated by exon-specific U1 small nuclear RNA. Am J Hum Genet 96:93–103.
-
(2015)
Am J Hum Genet
, vol.96
, pp. 93-103
-
-
Dalmas, A.1
Rogalska, M.E.2
Bussani, E.3
Pagani, F.4
-
10
-
-
84861134371
-
An exon-specific U1 small nuclear RNA (SnRNA) strategy to correct splicing defects
-
Fernandez Alanis E, Pinotti M, Dal Mas A, Balestra D, Cavallari N, Rogalska ME, Bernardi F, Pagani F. 2012. An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects. Hum Mol Genet 21:2389–2398.
-
(2012)
Hum Mol Genet
, vol.21
, pp. 2389-2398
-
-
Fernandez Alanis, E.1
Pinotti, M.2
Dal Mas, A.3
Balestra, D.4
Cavallari, N.5
Rogalska, M.E.6
Bernardi, F.7
Pagani, F.8
-
11
-
-
84860363361
-
Analysis of alternative splicing of cassette exons at single-cell level using two fluorescent proteins
-
Gurskaya NG, Staroverov DB, Zhang L, Fradkov AF, Markina NM, Pereverzev AP, Lukyanov KA. 2012. Analysis of alternative splicing of cassette exons at single-cell level using two fluorescent proteins. Nucleic Acids Res 40:e57.
-
(2012)
Nucleic Acids Res
, vol.40
-
-
Gurskaya, N.G.1
Staroverov, D.B.2
Zhang, L.3
Fradkov, A.F.4
Markina, N.M.5
Pereverzev, A.P.6
Lukyanov, K.A.7
-
12
-
-
16944365648
-
Identification of a splice site mutation (2789 +5 G
-
Highsmith WE Jr, Burch LH, Zhou Z, Olsen JC, Strong TV, Smith T, Friedman KJ, Silverman LM, Boucher RC, Collins FS, Knowles MR. 1997. Identification of a splice site mutation (2789 +5 G
-
(1997)
Hum Mutat
, vol.9
, pp. 332-338
-
-
Highsmith, W.E.1
Burch, L.H.2
Zhou, Z.3
Olsen, J.C.4
Strong, T.V.5
Smith, T.6
Friedman, K.J.7
Silverman, L.M.8
Boucher, R.C.9
Collins, F.S.10
Knowles, M.R.11
-
13
-
-
33846574156
-
Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia
-
Hims MM, Ibrahim EC, Leyne M, Mull J, Liu L, Lazaro C, Shetty RS, Gill S, Gusella JF, Reed R, Slaugenhaupt SA. 2007. Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia. J Mol Med (Berl) 85:149–161.
-
(2007)
J Mol Med (Berl)
, vol.85
, pp. 149-161
-
-
Hims, M.M.1
Ibrahim, E.C.2
Leyne, M.3
Mull, J.4
Liu, L.5
Lazaro, C.6
Shetty, R.S.7
Gill, S.8
Gusella, J.F.9
Reed, R.10
Slaugenhaupt, S.A.11
-
15
-
-
84856431819
-
RNA therapeutics: Beyond RNA interference and antisense oligonucleotides
-
Kole R, Krainer AR, Altman S. 2012. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 11:125–140.
-
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 125-140
-
-
Kole, R.1
Krainer, A.R.2
Altman, S.3
-
16
-
-
84901020910
-
Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicingmutations causing cystic fibrosis
-
Masvidal L, Igreja S, Ramos MD, Alvarez A, de Gracia J, Ramalho A, Amaral MD, Larriba S, Casals T. 2014. Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicingmutations causing cystic fibrosis. Eur J Hum Genet 22:784–791.
-
(2014)
Eur J Hum Genet
, vol.22
, pp. 784-791
-
-
Masvidal, L.1
Igreja, S.2
Ramos, M.D.3
Alvarez, A.4
De Gracia, J.5
Ramalho, A.6
Amaral, M.D.7
Larriba, S.8
Casals, T.9
-
17
-
-
84874094442
-
HGF stimulation of Rac1 signaling enhances pharmacological correction of themost prevalent cystic fibrosismutant F508del-CFTR
-
Moniz S, Sousa M, Moraes BJ, Mendes AI, Palma M, Barreto C, Fragata JI, Amaral MD, Matos P. 2013. HGF stimulation of Rac1 signaling enhances pharmacological correction of themost prevalent cystic fibrosismutant F508del-CFTR. ACS Chem Biol 8:432–442.
-
(2013)
ACS Chem Biol
, vol.8
, pp. 432-442
-
-
Moniz, S.1
Sousa, M.2
Moraes, B.J.3
Mendes, A.I.4
Palma, M.5
Barreto, C.6
Fragata, J.I.7
Amaral, M.D.8
Matos, P.9
-
18
-
-
10044270719
-
Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation
-
Nissim-Rafinia M, Aviram M, Randell SH, Shushi L, Ozeri E, Chiba-Falek O, Eidelman O, Pollard HB, Yankaskas JR, Kerem B. 2004. Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation. EMBO Rep 5:1071–1077.
-
(2004)
EMBO Rep
, vol.5
, pp. 1071-1077
-
-
Nissim-Rafinia, M.1
Aviram, M.2
Randell, S.H.3
Shushi, L.4
Ozeri, E.5
Chiba-Falek, O.6
Eidelman, O.7
Pollard, H.B.8
Yankaskas, J.R.9
Kerem, B.10
-
19
-
-
84880030599
-
Management of comorbidities in older patients with cystic fibrosis
-
Plant BJ, Goss CH, Plant WD, Bell SC. 2013. Management of comorbidities in older patients with cystic fibrosis. Lancet Respir Med 1:164–174.
-
(2013)
Lancet Respir Med
, vol.1
, pp. 164-174
-
-
Plant, B.J.1
Goss, C.H.2
Plant, W.D.3
Bell, S.C.4
-
20
-
-
0036846329
-
Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis
-
Ramalho A.S, Beck S, Meyer M, Penque D, Cutting GR, Amaral MD.2002. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol 27:619–627.
-
(2002)
Am J Respir Cell Mol Biol
, vol.27
, pp. 619-627
-
-
Ramalho, A.S.1
Beck, S.2
Meyer, M.3
Penque, D.4
Cutting, G.R.5
Amaral, M.D.6
-
21
-
-
85051362213
-
Comparative ex vivo, in vitro and in silico analyses of a CFTR splicing mutation: Importance of functional studies to establish disease liability of mutations
-
Ramalho AS, Clarke LA, Sousa M, Felicio V, Barreto C, Lopes C, Amaral MD. 2015. Comparative ex vivo, in vitro and in silico analyses of a CFTR splicing mutation: Importance of functional studies to establish disease liability of mutations. J Cyst Fibros.[Epub ahead of print].
-
(2015)
J Cyst Fibros
-
-
Ramalho, A.S.1
Clarke, L.A.2
Sousa, M.3
Felicio, V.4
Barreto, C.5
Lopes, C.6
Amaral, M.D.7
-
22
-
-
84873022115
-
Pick one, but be quick: 5’ splice sites and the problems of too many choices
-
Roca X, Krainer AR, Eperon IC. 2013. Pick one, but be quick: 5’ splice sites and the problems of too many choices. Genes Dev 27:129–144.
-
(2013)
Genes Dev
, vol.27
, pp. 129-144
-
-
Roca, X.1
Krainer, A.R.2
Eperon, I.C.3
-
23
-
-
84908665879
-
Experimental assessment of splicing variants using expressionminigenes and comparison with in silico predictions
-
Sharma N, Sosnay PR, Ramalho AS, Douville C, Franca A, Gottschalk LB, Park J, Lee M, Vecchio-Pagan B, Raraigh KS, Amaral MD, Karchin R, Cutting GR. 2014. Experimental assessment of splicing variants using expressionminigenes and comparison with in silico predictions. Hum Mutat 35:1249–1259.
-
(2014)
Hum Mutat
, vol.35
, pp. 1249-1259
-
-
Sharma, N.1
Sosnay, P.R.2
Ramalho, A.S.3
Douville, C.4
Franca, A.5
Gottschalk, L.B.6
Park, J.7
Lee, M.8
Vecchio-Pagan, B.9
Raraigh, K.S.10
Amaral, M.D.11
Karchin, R.12
Cutting, G.R.13
-
24
-
-
32044445564
-
Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron
-
Singh NK, Singh NN, Androphy EJ, Singh RN. 2006. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol 26:1333–1346.
-
(2006)
Mol Cell Biol
, vol.26
, pp. 1333-1346
-
-
Singh, N.K.1
Singh, N.N.2
Rophy, E.J.3
Singh, R.N.4
-
25
-
-
84885022205
-
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
-
Sosnay PR, Siklosi KR, Van Goor F, Kaniecki K, Yu H, Sharma N, Ramalho AS, Amaral MD, Dorfman R, Zielenski J, Masica DL, Karchin R, et al. 2013. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet 45:1160–1167.
-
(2013)
Nat Genet
, vol.45
, pp. 1160-1167
-
-
Sosnay, P.R.1
Siklosi, K.R.2
Van Goor, F.3
Kaniecki, K.4
Yu, H.5
Sharma, N.6
Ramalho, A.S.7
Amaral, M.D.8
Dorfman, R.9
Zielenski, J.10
Masica, D.L.11
Karchin, R.12
-
26
-
-
84858405200
-
Splice modulating therapies for human disease
-
Spitali P, Aartsma-Rus A. 2012. Splice modulating therapies for human disease. Cell 148:1085–1088.
-
(2012)
Cell
, vol.148
, pp. 1085-1088
-
-
Spitali, P.1
Aartsma-Rus, A.2
-
27
-
-
49649108878
-
A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators
-
Stoilov P, Lin CH, Damoiseaux R, Nikolic J, Black DL. 2008. A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators. Proc Natl Acad Sci USA 105:11218–11223.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 11218-11223
-
-
Stoilov, P.1
Lin, C.H.2
Damoiseaux, R.3
Nikolic, J.4
Black, D.L.5
-
28
-
-
45249091505
-
Substances that can change alternative splice-site selection
-
Sumanasekera C, Watt DS, Stamm S. 2008. Substances that can change alternative splice-site selection. Biochem Soc Trans 36(Pt 3):483–490.
-
(2008)
Biochem Soc Trans
, vol.36
, Issue.3
, pp. 483-490
-
-
Sumanasekera, C.1
Watt, D.S.2
Stamm, S.3
-
29
-
-
84900835509
-
New developments in exon skipping and splice modulation therapies for neuromuscular diseases
-
Touznik A, Lee JJ, Yokota T. 2014. New developments in exon skipping and splice modulation therapies for neuromuscular diseases. Expert Opin Biol Ther 14:809–819.
-
(2014)
Expert Opin Biol Ther
, vol.14
, pp. 809-819
-
-
Touznik, A.1
Lee, J.J.2
Yokota, T.3
-
30
-
-
60349104299
-
The spliceosome: Design principles of a dynamic RNP machine
-
Wahl MC, Will C.L, Luhrmann R. 2009. The spliceosome: design principles of a dynamic RNP machine. Cell 136:701–718.
-
(2009)
Cell
, vol.136
, pp. 701-718
-
-
Wahl, M.C.1
Will, C.L.2
Luhrmann, R.3
-
31
-
-
84904544984
-
Non-viral vectors for gene-based therapy
-
Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. 2014. Non-viral vectors for gene-based therapy. Nat Rev Genet 15:541–555.
-
(2014)
Nat Rev Genet
, vol.15
, pp. 541-555
-
-
Yin, H.1
Kanasty, R.L.2
Eltoukhy, A.A.3
Vegas, A.J.4
Dorkin, J.R.5
Erson, D.G.6
|